The Valley Desk

Case reportJCEM case reportsPublished

Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Hospital of the University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Case report
Venue
JCEM case reports
Published
Subject terms
Fibrous Dysplasia; Hypophosphatemia; Bone Pain; Fgf-23; Burosumab
PubMed ID
42100588
PubMed Central ID
PMC13148166
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal